MacroGenics and Sagard Healthcare Partners Enter into Expanded ZYNYZ® Royalty Purchase Agreement
· macrogenics, inc.
AI Briefing
- MacroGenics receives $60 million cash payment from Sagard Healthcare Partners, with potential for additional $20 million milestone.
- MacroGenics and Sagard Healthcare Partners enter into expanded royalty purchase agreement.
- No further details provided.
Advertisement